Skip to main content

Iradimed Corp

IRMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001325618

In the last 90 days, Iradimed Corp insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $750.2M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Iradimed Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
97
+23 vs. Q3 2021
Shares held
5.00M
+273.4K (+5.8%) vs. Q3 2021
Total value
$230.9M
+$72.1M (+45.4%) vs. Q3 2021
New holders
32
28 more added
Sold out
9
23 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IRMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 97 institutions
Q1 2021: 55 institutionsQ2 2021: 62 institutionsQ3 2021: 75 institutionsQ4 2021: 97 institutionsQ1 2022: 104 institutionsQ2 2022: 91 institutionsQ3 2022: 87 institutionsQ4 2022: 80 institutionsQ1 2023: 91 institutionsQ2 2023: 113 institutionsQ3 2023: 115 institutionsQ4 2023: 120 institutionsQ1 2024: 127 institutionsQ2 2024: 139 institutionsQ3 2024: 145 institutionsQ4 2024: 167 institutionsQ1 2025: 168 institutionsQ2 2025: 162 institutionsQ3 2025: 185 institutionsQ4 2025: 218 institutionsQ1 2026: 228 institutionsQ2 2026: 213 institutions
Value heldQ4 2021: $230.9M
Q1 2021: $122.2MQ2 2021: $140.5MQ3 2021: $158.8MQ4 2021: $230.9MQ1 2022: $241.0MQ2 2022: $187.5MQ3 2022: $169.1MQ4 2022: $156.7MQ1 2023: $227.5MQ2 2023: $292.9MQ3 2023: $270.7MQ4 2023: $306.7MQ1 2024: $295.4MQ2 2024: $299.8MQ3 2024: $340.3MQ4 2024: $383.4MQ1 2025: $365.3MQ2 2025: $421.6MQ3 2025: $492.4MQ4 2025: $722.7MQ1 2026: $734.3MQ2 2026: $750.2M
Institutions holding IRMD and their total value by quarter
QuarterHoldersValue
Q2 2026213$750.2M
Q1 2026228$734.3M
Q4 2025218$722.7M
Q3 2025185$492.4M
Q2 2025162$421.6M
Q1 2025168$365.3M
Q4 2024167$383.4M
Q3 2024145$340.3M
Q2 2024139$299.8M
Q1 2024127$295.4M
Q4 2023120$306.7M
Q3 2023115$270.7M
Q2 2023113$292.9M
Q1 202391$227.5M
Q4 202280$156.7M
Q3 202287$169.1M
Q2 202291$187.5M
Q1 2022104$241.0M
Q4 202197$230.9M
Q3 202175$158.8M
Q2 202162$140.5M
Q1 202155$122.2M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Iradimed Corp; share changes are against Q3 2021.

Institutions holding IRMD in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Citadel Advisors LLC0$00.00%−7,086−100.0%Sold out
Trexquant Investment LP0$00.00%−6,882−100.0%Sold out
LPL Financial LLC0$00.00%−6,050−100.0%Sold out
JFS Wealth Advisors, LLC0$00.00%−1,750−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−52−100.0%Sold out
Meridian Wealth Partners, LLC0$00.00%−8−100.0%Sold out
Berman Capital Advisors, LLC––––Not filed